Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologies

August 10, 2026 updated by: youssef alaa

Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologies (Randomized Controlled Clinical Trial & In-Vitro Study)

The clinical study aimed to evaluate the clinical performance, color stability, and wear of indirect composite veneers produced using 3D printing and milling technologies.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies. The veneers will be divided into two groups according to the technique of fabrication. Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC). Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year. Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Alexandria, Egypt
        • Faculty of dentistry, Alexandria university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Healthy adult patients aged 18 to 45 years.
  • Patients requiring veneer restorations due to discoloration, misalignment, tooth malformation or having irregular tooth shape that can be treated without full coverage.
  • Patients meeting the criteria for Class I or Class II veneers according to the LeSage veneer classification system.
  • Patients requiring veneers restorations on their bilateral maxillary anterior teeth.
  • The selected teeth should be vital with absence of clinical signs and symptoms of periapical pathology.
  • Patients having a normal occlusal relationship between upper and lower teeth (class I Angle classification).
  • Patients capable of tolerating rubber dam applications.
  • Patients willing to attend regular follow-up appointments.

Exclusion Criteria:

  • Bad oral hygiene (Oral Hygiene Index Simplified >3).
  • Non-vital teeth or endodontically treated teeth.
  • Severe periodontal disease.
  • Patients with para-functional habits (e.g., bruxism, attrition, wear facets).
  • Dentin exposure more than 20% of the prepared surface for veneer.
  • Prescence of smoking/vaping habits

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego)
Other: Group I (n=28): were restored with VarseoSmile TriniQ, Bego
A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies. The veneers will be divided into two groups according to the technique of fabrication. Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC). Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year. Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.
Active Comparator: group II: 28 veneers will be done using milling technology (Cerasmart 270, GC)
Other: Group II (n=28): were restored with Cerasmart 270, GC
A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies. The veneers will be divided into two groups according to the technique of fabrication. Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC). Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year. Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The functional properties of the examined veneer restorations
Time Frame: 1 year
All veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, and 12 months, following the FDI evaluation criteria and scoring system, which indicates: Functional properties: (F1) Fracture of material and retention. (F2) Marginal adaptation. (F3) Proximal contact point. (F4) Form and contour. (F5) Occlusion and wear. Each evaluated property was scored according to the FDI criteria using the following clinical scores: Score 1: Clinically excellent/very good (VG), Score 2: Clinically good (CG), score 3: Clinically satisfactory (CS), score 4: Clinically unsatisfactory (CU), score 5: Clinically poor (PO).
1 year
The biological properties of the examined veneer restorations
Time Frame: 1 year
All Veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, and 12 months, following the revised FDI evaluation criteria and scoring system, which indicates: Biological properties (B1) Caries at restoration margins. (B2) Dental hard tissue defects at the restoration margin. (B3) Postoperative hypersensitivity and pulpal status. Each evaluated property was scored according to the FDI criteria using the following clinical scores: Score 1: Clinically excellent/very good (VG), Score 2: Clinically good (CG), Score 3: Clinically satisfactory (CS), Score 4: Clinically unsatisfactory (CU), Score 5: Clinically poor (PO).
1 year
The aesthetic properties of the examined veneers
Time Frame: 1 year
All veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, and 12 months, following the FDI evaluation criteria and scoring system, which indicates: Aesthetic properties: (A1) Surface luster and surface texture. (A2) Marginal staining. (A3) Color match. Each evaluated property was scored according to the FDI criteria using the following clinical scores: Score 1: Clinically excellent/very good (VG), Score 2: Clinically good (CG), Score 3: Clinically satisfactory (CS), Score 4: Clinically unsatisfactory (CU), Score 5: Clinically poor (PO).
1 year
The color stability of the examined veneers
Time Frame: 1 year
All Veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, 9, and 12 months using the vita easy shade spectrophotometer. The CIEDE2000 formula will be used to measure the color change.
1 year
Wear resistance of the examined veneers
Time Frame: 1 year
All Veneers were scanned clinically using an intra oral scanner at 1 week (baseline) and subsequently at 3, 6, and 12 months. The different scans were compared to baseline scan to assess the volume loss and accordingly the wear resistant.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

youssef alaa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Actual)

August 5, 2026

Study Completion (Actual)

August 5, 2026

Study Registration Dates

First Submitted

August 5, 2026

First Submitted That Met QC Criteria

August 5, 2026

First Posted (Actual)

August 10, 2026

Study Record Updates

Last Update Posted (Actual)

August 12, 2026

Last Update Submitted That Met QC Criteria

August 10, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 9262109

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe